Clinical Trial

Efgartigimod for Consolidation Therapy in gMG

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to evaluate the efficacy and safety of consolidation therapy with corticosteroids and/or immunosuppressants combined with efgartigimod in patients with generalized myasthenia gravis after the acute exacerbation.
Trial Details
NCT Number NCT07079020
Lead Sponsor Da, Yuwei, M.D.
Conditions Myasthenia Gravis
Enrollment 130 participants
Start Date 2025-07-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-22